Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity.
Crouch ER, Kraker RT, Wallace DK, Holmes JM, Repka MX, Collinge JE, Bremer DL, Gray ME, Smith HA, Steinkuller PG; Writing Committee for Pediatric Eye Disease Investigator Group. Crouch ER, et al. Among authors: holmes jm. JAMA Ophthalmol. 2020 Jan 1;138(1):14-20. doi: 10.1001/jamaophthalmol.2019.4488. JAMA Ophthalmol. 2020. PMID: 31697304 Free PMC article. Clinical Trial.
The Amblyopia Treatment Index.
Cole SR, Beck RW, Moke PS, Celano MP, Drews CD, Repka MX, Holmes JM, Birch EE, Kraker RT, Kip KE; Pediatric Eye Disease Investigator Group. Cole SR, et al. Among authors: holmes jm. J AAPOS. 2001 Aug;5(4):250-4. doi: 10.1067/mpa.2001.117097. J AAPOS. 2001. PMID: 11507585 Clinical Trial.
The amblyopia treatment study visual acuity testing protocol.
Holmes JM, Beck RW, Repka MX, Leske DA, Kraker RT, Blair RC, Moke PS, Birch EE, Saunders RA, Hertle RW, Quinn GE, Simons KA, Miller JM; Pediatric Eye Disease Investigator Group. Holmes JM, et al. Arch Ophthalmol. 2001 Sep;119(9):1345-53. doi: 10.1001/archopht.119.9.1345. Arch Ophthalmol. 2001. PMID: 11545641 Clinical Trial.
Amblyopia. Current clinical studies.
Holmes JM, Beck RW, Repka MX. Holmes JM, et al. Ophthalmol Clin North Am. 2001 Sep;14(3):393-8. doi: 10.1016/s0896-1549(05)70236-4. Ophthalmol Clin North Am. 2001. PMID: 11705138 Review.
Risk of amblyopia recurrence after cessation of treatment.
Holmes JM, Beck RW, Kraker RT, Astle WF, Birch EE, Cole SR, Cotter SA, Donahue S, Everett DF, Hertle RW, Keech RV, Paysse E, Quinn GF, Repka MX, Scheiman MM; Pediatric Eye Disease Investigator Group. Holmes JM, et al. J AAPOS. 2004 Oct;8(5):420-8. doi: 10.1016/S1091853104001612. J AAPOS. 2004. PMID: 15492733 Clinical Trial.
393 results